Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

OBJECTIVE: We evaluated the activity and safety of the combination of topotecan, cisplatin and bevacizumab in patients with recurrent or persistent carcinoma of the cervix. METHODS: Eligible patients had persistent or recurrent cervical cancer not amenable to curative intent treatment. No prior chem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zighelboim, Israel, Wright, Jason D., Gao, Feng, Case, Ashley S., Massad, L. Stewart, Mutch, David G., Powell, Matthew A., Thaker, Premal H., Eisenhauer, Eric L., Cohn, David E., Valea, Fidel A., Secord, Angeles Alvarez, Lippmann, Lynne T., Dehdashti, Farrokh, Rader, Janet S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870479/
https://ncbi.nlm.nih.gov/pubmed/23591400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.04.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados